<DOC>
	<DOCNO>NCT00438490</DOCNO>
	<brief_summary>Medications use increase breast milk production increase prolactin secretion , main hormone lactation . There FDA approve medication use improve breast feeding , metoclopramide use off-label intolerable side effect . We examine biological activity safety recombinant human prolactin ( r-hPRL ) potential medication augment lactation . In study , effect r-hPRL breast milk production woman recently deliver baby effect bone menstrual cycle test .</brief_summary>
	<brief_title>The Safety Efficacy Recombinant Human Prolactin</brief_title>
	<detailed_description>There FDA approve medication U.S. augment lactation . Metoclopramide use off-label intolerable side effect . We examine biological activity safety recombinant human prolactin ( r-hPRL ) preliminary data use augment lactation . Healthy , non-postpartum woman ( n=21 ) regular menstrual cycle underwent 7 day randomize , double-blind , placebo-controlled trial r-hPRL . Galactorrhea , marker bone turnover , calcium homeostasis gonadal function measure side effect record .</detailed_description>
	<criteria>Healthy Subjects meet follow criterion : 1 . 18 40 year age 2 . Normal weight ( BMI 17 Â£ 30 kg/m2 ) 3 . Good general health 4 . On medication least 3 month study 5 . Regular menstrual cycle every 2535 day ovulation document luteal phase progesterone level 6 . No evidence androgen excess 7 . Normal TSH , prolactin hematocrit 8 . No current interest conception 9 . No history osteoporosis 10 . No use medication know affect bone turnover 11 . No alcoholism 12 . No smoke 13 . No history medical problem treatment know affect bone turnover . Subjects exclude pregnancy evidence breast mass .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>galactorrhea</keyword>
	<keyword>prolactin</keyword>
	<keyword>bone turnover</keyword>
	<keyword>menstrual cycle</keyword>
	<keyword>Control Groups</keyword>
	<keyword>Women</keyword>
</DOC>